Anupam Rasayan (NSE, BSE: ANURAS), one of India's leading custom synthesis & speciality chemical player, has signed long term binding contract worth Rs 135 crore with Japanese multinational customer for supplying an existing life science related speciality chemical. The company earlier signed LOI for this product with same customer and now have entered into a long-term contract for next four years.
Speaking about the order, Anand Desai, Managing Director of Anupam Rasayan, said, "We are delighted to inform you that we have signed yet another long-term binding contract with one of the top global chemical company. This conversion of LOI into a long-term contract reinforces the capability of our company to be a preferred partner with some of the world's most marquee companies. We continue to work on expanding our chemistries and enhance the wallet share with our customers."
The speciality chemicals major is manufacturing products for over 66 domestic and international customers, including 23 multinational companies. The company has a long history of high customer retention and have been manufacturing products for select customers for over a decade. The company caters to a diverse base of Indian and global customers.
Shares of Anupam Rasayan India Limited was last trading in BSE at Rs. 840.70 as compared to the previous close of Rs. 832.15. The total number of shares traded during the day was 292439 in over 1011 trades.
The stock hit an intraday high of Rs. 848.25 and intraday low of 823.25. The net turnover during the day was Rs. 242763848.00.